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Characterization of microbiology and associated antibiotic usage in the neonatal intensive care unit
• Antibiotics are the most commonly administered 
medications in the neonatal intensive care unit (NICU).1
• Antibiotic usage in neonatal patients may be associated 
with significant adverse effects.2
• A sepsis calculator was implemented on April 1, 2019 to 
evaluate infection risk in infants 36 weeks gestation or 
older with goal to reduce unnecessary empiric antibiotic 
treatment.
• Surveillance cultures are collected to detect colonization 
and limit the transmission of methicillin-resistant 
Staphylococcus aureus (MRSA).3
• Goal of this research project was to evaluate culture 
results, surveillance cultures and antibiotic use in the 
NICU at Lehigh Valley Reilly Children’s Hospital (LVRCH)
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Table 1. Patient demographics 
Table 2. Microbiology of documented infections and surveillance cultures
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A retrospective chart review was performed for 
neonates admitted to the NICU within LVRCH who 
received at least one dose of antibiotics between 
April 1, 2018 and March 31, 2020.
The study sample was summarized using descriptive 
statistics.
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• Characterize empiric 
antimicrobial therapy 
based on postmenstrual 
age.
Secondary Objectives
• Calculate percentage of 
documented infections 
and characterize infecting 
organisms
• Calculate percentage of 




Figure 2. Positive surveillance cultures with respect to 

















































































































Gestational Age, n (%)
20 weeks 1 day to 23 weeks 6 days
24 weeks 0 days to 27 weeks 6 days
28 weeks 0 days to 31 weeks 6 days
32 weeks 0 days to 36 weeks 6 days
















Male gender, n (%) 382 (58) 209 (55) 173 (61)
Birth Weight (kg), median (IQR) 2.82 (0.45-1.77) 3.08 2.51
• Ampicillin/gentamicin was the most frequently prescribed 
empiric antimicrobial regimen in the first week of life, whereas 
vancomycin/gentamicin was encountered more frequently in 
infants beyond 7 days of life. 
• Documented infection rate for the NICU at LVRCH was similar 
across the two time periods and remains low based on size 
and level of care. Gram-negative and gram-positive organisms 
were encountered similarly during the two timeframes.
• Less than 25% of patients were colonized during their NICU 
hospitalization. Majority of patients were colonized after a 
three week hospital stay. MSSA represented more than two-
thirds of positive surveillance cultures.
• Antimicrobial days of therapy have steadily declined over the 
study period. This could be attributed to implementation of 
the sepsis calculator and less empiric use of antimicrobials.
*Percentage of documented infections calculated 
as number of infections divided by number of 
admissions for each year





< 7 days ≥ 7 days
Figure 1. Empiric Antibiotic Usage with Respect to Postmenstrual 
Age
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